Biosyntech (Biosyntech) Accounts Payable

: $0.00 Mil (As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

Biosyntech's Accounts Payable for the quarter that ended in Dec. 2009 was $0.00 Mil.

Biosyntech's annual Accounts Payable increased from Mar. 2007 ($0.49 Mil) to Mar. 2008 ($0.65 Mil) but then declined from Mar. 2008 ($0.65 Mil) to Mar. 2009 ($0.39 Mil).

Biosyntech Accounts Payable Historical Data

The historical data trend for Biosyntech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Accounts Payable

0.55

1.03

0.49

0.65

0.39

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Accounts Payable																2.41	0.39	-	-	-

Biosyntech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Biosyntech Accounts Payable Related Terms

Thank you for viewing the detailed overview of Biosyntech's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines